News

Fujifilm lands another drugmaker to new Holly Springs plant with $3 billion deal
Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly ...
Regeneron expands US manufacturing with $3B Fujifilm partnership
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily ...
FujiFilm lands $3B manufacturing deal with Regeneron in Holly Springs
FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is ...
GEN - Genetic Engineering and Biotechnology News5d
FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $3+ Billion U.S. Manufacturing Deal
FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.
Fierce Pharma5d
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...
Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...
NC Biotech6d
Corporate recombinations include $50M, new life for Durham’s Pelthos
Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...